Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

87.75 

0.41 0.5%

as of Aug 19 '19

52 Week Range:

69.36 94.85


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; offers specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in both the companion animal and production animal markets, as well as provides demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18
Equity (BVPS) 8.82
9.43
10.65
10.98
12.44
10.51
8.95
7.62
8.54
11.71
14.53
growth rate 6.9% 12.9% 3.1% 13.3% -15.5% -14.8% -14.9% 12.1% 37.1% 24.1%
Earnings BIT 761.34
824.07
1,030.00
1,130.00
1,160.00
824.46
1,188.59
1,307.35
1,682.80
2,018.29
1,650.95
growth rate 8.2% 25.0% 9.7% 2.7% -28.9% 44.2% 10.0% 28.7% 19.9% -18.2%
Avg.PE 13.02
13.25
13.81
14.66
14.03
29.07
77.29
753.59
12.43
21.16
11.61
growth rate 1.8% 4.2% 6.2% -4.3% 107.2% 165.9% 875.0% -98.4% 70.2% -45.1%
ROA 2.04
3.90
4.55
4.80
4.73
2.52
1.37
-0.55
4.65
1.06
4.54
growth rate 91.2% 16.7% 5.5% -1.5% -46.7% -45.6% -100.0% 100.0% -77.2% 328.3%
ROE 8.63
18.55
22.46
24.28
27.01
18.16
12.93
-10.41
103.36
17.38
66.37
growth rate 115.0% 21.1% 8.1% 11.2% -32.8% -28.8% -100.0% 100.0% -83.2% 281.9%
ROIC 6.09
13.85
16.64
17.69
20.07
12.54
8.06
-4.54
28.39
7.13
29.78
growth rate 127.4% 20.1% 6.3% 13.5% -37.5% -35.7% -100.0% 100.0% -74.9% 317.7%
Cur. Ratio 1.06
1.05
1.08
1.03
0.98
0.97
0.97
0.90
0.90
0.91
0.93
growth rate -0.9% 2.9% -4.6% -4.9% -1.0% 0.0% -7.2% 0.0% 1.1% 2.2%
Quick Ratio 0.53
0.52
0.55
0.52
0.45
0.49
0.47
0.46
0.47
0.47
0.50
growth rate -1.9% 5.8% -5.5% -13.5% 8.9% -4.1% -2.1% 2.2% 0.0% 6.4%
Leverage 4.51
5.00
4.89
5.23
6.29
8.16
11.00
43.78
15.81
17.11
12.84
growth rate 10.9% -2.2% 7.0% 20.3% 29.7% 34.8% 298.0% -63.9% 8.2% -25.0%
Balance Sheet Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18
Acct.Receivable 3,480.30
3,916.50
3,827.50
3,793.85
3,784.62
6,051.92
6,312.88
8,222.95
9,175.88
10,303.32
11,314.23
growth rate 12.5% -2.3% -0.9% -0.2% 59.9% 4.3% 30.3% 11.6% 12.3% 9.8%
Acct.Payable 10,440.64
11,025.88
14,870.64
15,592.83
20,886.44
23,926.32
25,404.04
26,836.87
growth rate 5.6% 34.9% 4.9% 34.0% 14.6% 6.2% 5.6%
Cur.Assets 8,669.80
9,953.80
10,748.40
11,375.04
11,058.46
14,393.65
16,800.21
20,334.49
22,851.85
24,303.30
25,894.37
growth rate 14.8% 8.0% 5.8% -2.8% 30.2% 16.7% 21.0% 12.4% 6.4% 6.6%
Total Assets 12,217.80
13,572.70
14,434.80
14,982.67
15,442.26
18,918.64
21,532.18
27,962.98
33,637.50
35,316.47
37,669.84
growth rate 11.1% 6.4% 3.8% 3.1% 22.5% 13.8% 29.9% 20.3% 5.0% 6.7%
Cash 878.10
1,009.40
1,658.20
1,825.99
1,066.61
1,231.01
1,808.51
2,167.44
2,741.83
2,435.12
2,492.52
growth rate 15.0% 64.3% 10.1% -41.6% 15.4% 46.9% 19.9% 26.5% -11.2% 2.4%
Inventory 4,211.80
4,972.80
5,210.10
5,443.10
5,472.01
6,981.49
8,593.85
9,755.09
10,723.92
11,461.43
11,918.51
growth rate 18.1% 4.8% 4.5% 0.5% 27.6% 23.1% 13.5% 9.9% 6.9% 4.0%
Cur.Liabilities 8,167.60
9,479.60
9,906.30
10,875.26
11,265.59
14,870.64
17,250.16
21,578.23
25,280.37
26,818.17
27,869.69
growth rate 16.1% 4.5% 9.8% 3.6% 32.0% 16.0% 25.1% 17.2% 6.1% 3.9%
Liabilities 9,507.70
10,856.30
11,480.50
12,115.81
12,987.41
16,598.89
19,575.28
27,346.60
31,508.10
33,252.01
34,619.88
growth rate 14.2% 5.8% 5.5% 7.2% 27.8% 17.9% 39.7% 15.2% 5.5% 4.1%
LT Debt 1,187.40
1,176.90
1,343.20
972.86
1,395.93
1,396.61
1,995.63
3,739.23
3,852.48
3,781.57
4,510.83
growth rate -0.9% 14.1% -27.6% 43.5% 0.1% 42.9% 87.4% 3.0% -1.8% 19.3%
Equity 2,710.00
2,716.50
2,954.30
2,866.86
2,454.84
2,319.75
1,956.90
616.39
2,129.40
2,064.46
2,932.82
growth rate 0.2% 8.8% -3.0% -14.4% -5.5% -15.6% -68.5% 245.5% -3.1% 42.1%
Common Shares 325.00
303.00
287.00
278.00
257.00
235.00
235.00
218.00
226.00
222.00
220.00
growth rate -6.8% -5.3% -3.1% -7.6% -8.6% 0.0% -7.2% 3.7% -1.8% -0.9%
Cash Flow Statement Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18
Capital Expenditures 134.30
-0.10
-0.30
156.14
133.29
202.45
264.46
231.59
464.62
466.40
336.41
growth rate -100.0% 0.0% 100.0% -14.6% 51.9% 30.6% -12.4% 100.6% 0.4% -27.9%
Cash Dividends 48.70
62.70
90.60
117.62
132.76
195.72
214.47
253.92
288.48
320.27
333.04
growth rate 28.8% 44.5% 29.8% 12.9% 47.4% 9.6% 18.4% 13.6% 11.0% 4.0%
Cash From OA 737.10
783.80
1,108.60
1,167.95
1,305.45
788.13
1,464.65
3,922.23
3,178.50
1,504.14
1,411.39
growth rate 6.3% 41.4% 5.4% 11.8% -39.6% 85.8% 167.8% -19.0% -52.7% -6.2%
FCF per Share 1.85
2.11
3.22
3.60
3.62
4.85
1.44
15.06
11.69
4.27
8.06
growth rate 14.1% 52.6% 11.8% 0.6% 34.0% -70.3% 945.8% -22.4% -63.5% 88.8%
Sale Purchase of Stock -685.05
-1,047.02
-328.46
81.57
105.88
2,435.25
102.92
growth rate 0.0% 0.0% 100.0% 29.8% 2,200.1% -95.8%
FCF 600.00
638.00
924.00
1,000.00
1,141.00
586.00
1,199.00
3,689.00
2,714.00
1,038.00
1,075.00
growth rate 6.3% 44.8% 8.2% 14.1% -48.6% 104.6% 207.7% -26.4% -61.8% 3.6%
Income Statement Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18
Sales 70,189.70
71,760.00
77,954.00
78,695.66
78,080.81
87,959.17
119,569.13
135,961.80
146,849.69
153,143.83
167,939.64
growth rate 2.2% 8.6% 1.0% -0.8% 12.7% 35.9% 13.7% 8.0% 4.3% 9.7%
Op.Income 827.90
883.70
1,103.60
697.50
761.36
493.44
1,188.59
1,307.35
1,682.80
2,018.29
1,650.95
growth rate 6.7% 24.9% -36.8% 9.2% -35.2% 140.9% 10.0% 28.7% 19.9% -18.2%
IBT 761.30
824.10
1,027.80
1,117.99
1,216.87
824.46
669.86
268.96
1,390.91
917.89
1,177.42
growth rate 8.3% 24.7% 8.8% 8.8% -32.3% -18.8% -59.9% 417.1% -34.0% 28.3%
Net Income 250.60
503.40
636.70
697.50
761.36
493.44
274.23
-138.17
1,427.93
364.48
1,658.41
growth rate 100.9% 26.5% 9.6% 9.2% -35.2% -44.4% -100.0% 100.0% -74.5% 355.0%
EPS 0.77
1.66
2.22
2.54
2.80
1.84
1.16
-0.63
6.32
1.64
7.53
growth rate 115.6% 33.7% 14.4% 10.2% -34.3% -37.0% -100.0% 100.0% -74.1% 359.2%
Gross Profit 2,047.00
2,100.10
2,356.60
2,458.98
2,634.69
2,507.82
2,957.93
3,463.82
4,138.85
4,544.61
4,576.38
growth rate 2.6% 12.2% 4.3% 7.2% -4.8% 18.0% 17.1% 19.5% 9.8% 0.7%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 429.12
254.19
431.25
621.03
463.22
growth rate -40.8% 69.7% 44.0% -25.4%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 11,764.61
11,314.23
11,979.38
12,222.27
11,989.03
growth rate -3.8% 5.9% 2.0% -1.9%
Acct.Payable 26,449.54
26,836.87
28,336.29
28,189.39
27,807.40
growth rate 1.5% 5.6% -0.5% -1.4%
Cur.Assets 26,404.40
25,894.37
27,476.21
27,622.18
27,401.78
growth rate -1.9% 6.1% 0.5% -0.8%
Total Assets 38,309.59
37,669.84
39,267.82
38,810.31
38,478.54
growth rate -1.7% 4.2% -1.2% -0.9%
Cash 2,388.93
2,492.52
2,540.16
2,875.75
2,999.56
growth rate 4.3% 1.9% 13.2% 4.3%
Inventory 12,074.35
11,918.51
11,800.19
11,373.73
11,247.78
growth rate -1.3% -1.0% -3.6% -1.1%
Cur.Liabilities 28,099.67
27,869.69
29,351.74
29,211.90
28,788.87
growth rate -0.8% 5.3% -0.5% -1.5%
Liabilities 35,033.66
34,619.88
36,103.09
35,771.98
35,371.34
growth rate -1.2% 4.3% -0.9% -1.1%
LT Debt 4,569.76
4,510.83
4,516.58
4,359.90
4,339.93
growth rate -1.3% 0.1% -3.5% -0.5%
Equity 3,097.82
2,932.82
3,048.45
2,921.22
2,989.42
growth rate -5.3% 3.9% -4.2% 2.3%
Common Shares 2.83
2.84
2.84
2.85
2.85
growth rate 0.1% 0.2% 0.1% 0.1%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 79.54
88.05
79.23
82.26
69.28
growth rate 10.7% -10.0% 3.8% -15.8%
Cash Dividends 83.43
82.08
85.54
84.89
84.64
growth rate -1.6% 4.2% -0.8% -0.3%
Cash From OA 823.29
665.35
478.97
624.36
567.87
growth rate -19.2% -28.0% 30.4% -9.1%
Sale Purchase of Stock 12.27
growth rate
FCF 743.74
577.29
399.74
542.11
498.59
growth rate -22.4% -30.8% 35.6% -8.0%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 43,142.31
43,297.14
45,392.45
43,319.60
45,239.27
growth rate 0.4% 4.8% -4.6% 4.4%
Op.Income 429.12
254.19
431.25
621.03
463.22
growth rate -40.8% 69.7% 44.0% -25.4%
IBT 345.20
111.87
432.56
18.78
371.12
growth rate -67.6% 286.7% -95.7% 1,875.7%
Net Income 275.81
233.29
393.65
27.14
301.96
growth rate -15.4% 68.7% -93.1% 1,012.8%
EPS
growth rate
Gross Profit 1,175.74
1,032.64
1,210.30
1,372.78
1,227.76
growth rate -12.2% 17.2% 13.4% -10.6%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (53.36)

YOY Growth Grade:

E (30.11)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 14.52 16.10 10.77
EPS / Growth 16.4% 5.45 10.1%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 14.8%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 10.1% 13.8% 13.8%
Future PE 10.77 17.61 17.61
Future EPS 14.29 19.80 19.80
Value Price
MOS %
38.04
-56.6%
86.20
-1.8%
86.20
-1.8%
MOS Price 19.02 43.10 43.10
IRT 9.41 8.37 8.37

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.